MarginsXMarginsX
Home › Markets › Health Care › CLPT

ClearPoint Neuro Inc. (CLPT)

CLPT trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$8.30
-2.12% on the day
Market cap
$266.1M
Micro cap
Revenue · 2025
$37.0M
+17.8% on 2024
Net income · 2025
-$25.5M
-69.1% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1285550/000119312526111231/0001193125-26-111231-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerCLPT on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001285550
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$37.0M
Net income-$25.5M
Operating income-$24.2M
Net margin-69.1%
Operating margin-65.4%
Revenue growth+17.8%
Cash$45.9M
Total assets$97.7M
P/E (computed)Net income was not positive
P/S (computed)7.2×

Warning signs

Cash runway
11.8 months
$46.2M cash at September 30, 2026
Share count, 1 year
+12.8%
2025-10-27 to 2026-10-21 · +30.2% over 3 years
Going-concern doubt
No
10-Q filed October 28, 2026
Insider net buying, 12 months
-$3.2M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-10-28
Cash and burn$46.2M cash; operating cash flow -$11.8M a quarter.Report 2026-09-30
Shares outstanding32,054,268 (2026-10-21); 28,423,308 a year earlier; 24,620,567 three years earlier.Cover page 2026-10-21
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-01-14
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorCherry Bekaert LLP, Tampa, Florida, United StatesPCAOB Form AP 2026-03-18
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $3.2M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$12.1M-$7.5M-$20.1M$46.2M$50.8M$45.5M10-Q 2026-10-28
Q2 2026
2026-06-30
$10.9M-$11.3M-$7.0M$29.4M$50.2M$42.3M10-Q 2026-08-03
Q1 2026
2026-03-31
$12.1M-$9.6M-$8.0M$35.6M$49.6M$40.6M10-Q 2026-05-13
Q4 2025
2025-12-31
$10.4M-$7.8M-$12.1M$45.9M$49.1M$37.0M10-K 2026-03-17
Q3 2025
2025-09-30
$8.9M-$5.9M-$3.1M$38.2M$29.2M$34.3M10-Q 2026-10-28
Q2 2025
2025-06-30
$9.2M-$5.8M-$2.6M$41.5M$28.8M$33.6M10-Q 2026-08-03
Q1 2025
2025-03-31
$8.5M-$6.0M-$6.2M$12.4MNo debt tags$32.2M10-Q 2026-05-13
Q4 2024
2024-12-31
$7.8M-$5.4M-$1.2M$20.1MNo debt tags$31.4M10-K 2026-03-17

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS
424B32026-01-22
Latest annual report10-K2026-03-17
Latest quarterly / interim10-Q2026-10-28
Latest current report8-K2026-10-28
Latest proxyDEFA14A2026-04-23

Source: SEC EDGAR submissions feed, 1,006 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-1.4%
1 month-13.6%
3 months-45.0%
Year to date-38.0%
1 year-45.3%
From 52-week high-56.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
PROFProfound Medical Corp.$7.34-1.08%$268.8M
SSIISS Innovations International Inc.$1.35-18.67%$270.7M
NPCENeuropace Inc.$7.97+5.42%$274.6M
OFIXOrthofix Medical Inc. Common Stock (DE)$6.80-5.16%$277.2M
OSUROraSure Technologies Inc.$3.60-0.55%$248.6M
TMCITreace Medical Concepts Inc.$4.42-16.13%$289.8M
INFUInfuSystems Holdings Inc.$14.79+0.48%$296.3M
PDEXPro-Dex Inc.$64.48-1.80%$206.3M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier